Abstract: The present disclosure provides systems and methods for identifying microbial signatures from samples that determine discriminant features between healthy control populations and diseased subjects or populations with specific disorders. The microbial signatures are used to diagnose, prognose or determine risk and/or severity of a disease or disorder in a subject, such as autism spectrum disorder or irritable bowel syndrome.

Abstract: The present disclosure relates to a food product comprising a pure fungi biomass, the pure fungi biomass comprising fungi of a species belonging to the genus Rhizopus, wherein the dry weight of the food product comprises within the range of from 10% to 100% of dry weight of the fungi biomass the fungi biomass comprising fungi biomass fibers, wherein 50% or more, such as 70% or more, or 80% or more of the fungi biomass fibers are aligned substantially in planes extending in a first direction. The present disclosure also relates to a method for producing the food product and use of a pure fungi biomass for preparing a food product.

Abstract: An embodiment of the present invention is directed to a code review tool. A system that implements a T24 code review tool comprises: a memory component; an interactive interface that receives one or more user inputs; a processor, coupled to the memory component and the interactive interface, the processor configured to perform the steps comprising: retrieve components of an application; initiate automated code review function for the components; identify code review comments prior to code compilation; display comments with severity for code review; and confirm and initiate code compilation process.

Abstract: A power management circuit and a method for operating a power management circuit are described. In one embodiment, a power management circuit includes power switching modules. Power is supplied to each of the power switching modules by at least one of multiple power sources. Each of the power switching modules includes a latch circuit configured to have a definite state at power-up of a corresponding power source and a logic circuit configured to control power supplied from the corresponding power source in response to the definite state of the latch circuit, where the logic circuit includes a cross-coupled circuit. Other embodiments are also described.

Abstract: A power management circuit and a method for operating a power management circuit are described. In one embodiment, a power management circuit includes power switching modules. Power is supplied to each of the power switching modules by at least one of multiple power sources. Each of the power switching modules includes a latch circuit configured to have a definite state at power-up of a corresponding power source and a logic circuit configured to control power supplied from the corresponding power source in response to the definite state of the latch circuit, where the logic circuit includes a cross-coupled circuit. Other embodiments are also described.

Abstract: Consistent with an example embodiment, a method of tracking a maximum power point (MPP) of a PV (photovoltaic) system comprises a circuit with a controller controlling a DC voltage-DC voltage converter for converting an output current of the PV system; the controller further comprises a memory. The method comprises measuring a first value of a PV system voltage at an initial MPP; storing said first value in said memory; periodically sampling a power output level of said PV system, and upon detecting a change in said power output level exceeding a first threshold, reading the first value from the memory; and adjusting a duty cycle of the DC voltage-DC voltage converter until the circuit voltage matches said first value; the method further comprising fine-tuning the duty cycle of the DC voltage-DC voltage converter to a further MPP following detecting a change in said power output level exceeding a first threshold.

Abstract: Disclosed is a method (400) of tracking a maximum power point (MPP) of a PV (photovoltaic) system (100) comprising a circuit (120) including a controller (124) controlling a DC voltage-DC voltage converter (126) for converting an output current of the photovoltaic system, the controller further comprising a memory, the method comprising measuring (412) a first value of a photovoltaic system voltage at an initial maximum power point; storing said first value in said memory; periodically sampling (406) a power output level of said photovoltaic system, and upon detecting a change in said power output level exceeding a first threshold, reading the first value from the memory; and adjusting (410) a duty cycle of the DC voltage-DC voltage converter until the circuit voltage matches said first value; the method further comprising fine-tuning (414) the duty cycle of the DC voltage-DC voltage converter to a further maximum power point following detecting a change in said power output level exceeding a first threshold.

Abstract: Polyvalent, primary isolate nucleic acid compositions for inducing an immune response against HIV is disclosed. The compositions and methods described herein are for the use of a DNA composition that encodes one or more different HIV envelope glycoproteins. The DNA composition can encode an HIV Gag protein. The DNAs encoding one or more HIV proteins are a combination of different nucleic acids, such as DNA plasmids, generated from primary isolate DNA of different HIV major group genetic clades and/or different proteins. HIV protein compositions for inducing an immune response against HIV are disclosed. Methods for using the protein compositions as boosts following administration of the DNA compositions are provided.

Abstract: Polyvalent, primary isolate nucleic acid compositions for inducing an immune response against HIV is disclosed. The composition and methods described herein are for the use of a DNA composition that encodes one or more different HIV envelope glycoproteins. The DNA composition can encode an HIV Gag protein. The DNAs encoding one or more HIV proteins are a combination of different nucleic acids, such as DNA plasmids, generated from primary isolate DNA of different HIV major group genetic clades and/or different proteins. HIV protein compositions for inducing an immune response against HIV are disclosed. Methods fro using the protein compositions as boosts following administration of the DNA compositions are provided.

Abstract: The present invention provides a method for determining the presence of prostate cancer in a subject which method comprises determining the level of expression of one or more markers in a blood sample from the subject, wherein said one or more markers comprise at least one of E2F3, c-met, pRB, EZH2, e-cad, CAXII, CAIX, HIF-1?, Jagged, PIM-1, hepsin, RECK, Clusterin, MMP9, MTSP-1, MMP24, MMP15, IGFBP-2, IGFBP-3, E2F4, caveolin, EF-1A, Kallikrein 2, Kallikrein 3 and PSGR.

Abstract: The present invention relates to nano sized sulfide compounds of cerium and a process for the preparation thereof. More particularly, the present invention provides novel nano sized particles of cerium sulfide as well as a novel process for the preparation of nano sized sulfide compounds of cerium by the bioreduction of cerium sulfate or cerium acetate, without resorting to chemical methods. A bioprocess is disclosed to treat trivalent Cerium salt with sulfate-reducing bacteria (SRB) under controlled conditions to obtain a biomass, which is subjected to staggered heating up to a temperature of 600-1500° C. The sulfide of Cerium is finally separated for application in pigment industry.

Abstract: A process of combination tannage is disclosed whereby Zirconium salt is complexed with THP salt to produce wet pink leather without using any conventional dye. The resulting leathers exhibit shrinkage temperature of more than 100° C. properties and other comparable to those of conventionally processed leathers.

Abstract: Conventionally skins/hides are tanned with metal-ions and vegetable tannins. Environmental constraints on the discharge of toxic metal-ions and poor biodegradable vegetable tannins in the wastewater have become serious issue. In this invention, the pelts are tanned using eco-benign bio-molecules other than vegetable tannins to reduce the pollution loads. Performance of the leathers is on par with conventionally processed leathers.

Abstract: The present invention provides a novel process for preparation of inorganic colourants from mixed rare earth compounds, which are directly obtained from the ore industry, without undergoing any separation, thereby enabling a cost reduction to the extend of 10-100 times. Colors ranging from brown, blue and green can be obtained by suitable doping with other metal ions.

Abstract: The present invention provides a process for preparing a bio-tanning agent from collagenous source.

Abstract: The use of lime and sodium sulfide in leather making creates a lot of environmental concern. However, there is no commercial beam house process that could totally eliminate the use of lime and sodium sulfide. In this invention, a novel bio-chemical process has been standardized employing specific enzymes and non-toxic chemical that could totally eliminate the use of lime and sodium sulfide in leather processing. It has been found that the extent of hair removal and opening up of fibre bundles is comparable to that of the conventional limed leathers. Performance of the leathers is shown to be on par with conventionally leathers. The process also enjoys reduction in chemical oxygen demand and total solids load compared to conventional process.

Abstract: Polyvalent, primary isolate nucleic acid compositions for inducing an immune response against HIV is disclosed. The compositions and methods described herein are for the use of a DNA composition that encodes one or more different HIV envelope glycoproteins. The DNA composition can encode an HIV Gag protein. The DNAs encoding one or more HIV proteins are a combination of different nucleic acids, such as DNA plasmids, generated from primary isolate DNA of different HIV major group genetic clades and/or different proteins. HIV protein compositions for inducing an immune response against HIV are disclosed. Methods for using the protein compositions as boosts following administration of the DNA compositions are provided.